Preemptive expression of protective alleles and response elements (PREPARE)
Ended Definitive Contract Awarded Last action
- Contract number
- HR001119C0060
- Awardee
-
Dnarx LLC UEI JDTQKQGBT921
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $1,629,492
Award facts
- Opportunity
-
- PReemptive Expression of Protective Alleles and Response Elements (PREPARE) Pre-Solicitation · HR001118S0037 · Posted Jun 6, 2018
- Development of a Rapidly-acting Preventative Therapy for Influenza Award Notice · Posted Jul 16, 2019
- Contract value 19% obligated
-
- $1,646,230.00 Current, with exercised options
- $8,761,470.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 14 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94158, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$16,738 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $333,730 | |
| Original award | $1,312,500 |
About this award
The Department of Defense's Defense Advanced Research Projects Agency (DARPA) awarded a $8,761,470.00 firm fixed-price contract to Dnarx LLC, a small disadvantaged business, for the Preemptive Expression of Protective Alleles and Response Elements (PREPARE) program. The PREPARE program aims to develop programmable gene modulators for humans that can provide specific, effective, safe, and transient medical countermeasures and prophylaxes to combat chemical, biological, radiological, and/or nuclear (CBRN) threats. This contract does not have a set-aside designation and the period of performance is scheduled to conclude on July 31, 2021. The contract was awarded on April 1, 2019 based on a pre-solicitation posted on June 6, 2018.
Quick answers
Who was awarded contract HR001119C0060?
HR001119C0060 was awarded to Dnarx LLC by Defense Advanced Research Projects Agency (Department of Defense) on April 1, 2019.
How much is contract HR001119C0060 worth?
The government has obligated $1,629,492 on HR001119C0060. Its current value, with exercised options, is $1,646,230. Its potential value, with all options, is $8,761,470.
Was contract HR001119C0060 competed?
The extent of competition for HR001119C0060 was full and open competition. The government received 14 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award